Berkeley Lights, Inc. (BLI)
| Market Cap | 3.06B |
| Revenue (ttm) | 64.30M |
| Net Income (ttm) | -41.58M |
| Shares Out | 31.19M |
| EPS (ttm) | -1.39 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | April 20 |
| Last Price | $46.76 |
| Previous Close | $46.88 |
| Change ($) | -0.12 |
| Change (%) | -0.26% |
| Day's Open | 46.96 |
| Day's Range | 45.29 - 47.58 |
| Day's Volume | 457,952 |
| 52-Week Range | 42.03 - 113.53 |
EMERYVILLE, Calif., April 12, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be reporting financial results for the firs...
EMERYVILLE, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- Today, Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, announced the launch of Opto Assure, a series of assays that provides...
EMERYVILLE, Calif., March 16, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be participating in the upcoming KeyBanc Li...
An important indicator for investors to consider could be a stock's 52-week trading range, the range shows the lowest and highest price that a particular stock has traded at over the last trailing 52 we...
EMERYVILLE, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be participating in the upcoming Cowen 41st ...
Berkeley Lights (BLI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Kurt Wood appointed CFO; Industry Veterans Pete Leddy, as CHRO, and Mimi Healy, as CPO, join Berkeley Lights
EMERYVILLE, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the Opto™ Plasma B Discovery 4.0 workflow. Opto Plasma B Disc...
EMERYVILLE, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be participating in the upcoming 39th Annual...
Berkeley Lights (BLI) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.
EMERYVILLE, Calif., Nov. 18, 2020 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc., a leader in Digital Cell Biology, today announced the pricing of its previously announced public offering of 3,000,000 shares...
EMERYVILLE, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc., a leader in Digital Cell Biology, today announced the launch of a public offering of 3,000,000 shares of common stock to be s...
Berkeley Lights, Inc. (BLI) CEO Eric Hobbs on Q3 2020 Results - Earnings Call Transcript
EMERYVILLE, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today reported financial results for the quarter ended September 30, 2020.
EMERYVILLE, Calif., Oct. 19, 2020 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be report financial results for the third qu...
Eric Hobbs discusses how Berkeley Lights is not just fighting COVID-19, but also accelerating the design-build-test cycle for all of synthetic biology.
MIAOLI, Taiwan and EMERYVILLE, Calif., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Mycenax Biotech, Inc. (4726.TWO), a pioneer of biopharmaceutical development in Taiwan, today announced its adoption of the Be...
EMERYVILLE, Calif., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the company will be participating in the upcoming Morgan S...
EMERYVILLE, Calif., Aug. 25, 2020 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today reported financial results for the quarter ended June 30, 2020.
EMERYVILLE, Calif., July 21, 2020 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc., (Nasdaq: BLI) a leader in Digital Cell Biology, today announced the closing of its initial public offering of 9,315,000 sha...
Shares of Berkeley Lights Inc. BLI, +134.09% took flight Friday, as the cell biology company went public at a price that was more than double what the upsized initial public offering was priced.
Berkeley Lights Inc. raised $178.2 million as the cell biology company's upsized initial public offering priced above the expected range.
About BLI
Berkeley Lights, Inc., a digital cell biology company, focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software. It serves in North America, the Asia Pacific, and Europe. The company was incorporated in 2011 and is headquartered in Emeryville, California.
| Industry Biotechnology | IPO Date Jul 17, 2020 |
| CEO Eric Hobbs | Employees 230 |
| Stock Exchange NASDAQ | Ticker Symbol BLI |
Financial Performance
In 2020, BLI's revenue was $64.30 million, an increase of 13.42% compared to the previous year's $56.69 million. Losses were -$41.58 million, 127.2% more than in 2019.
Analyst Forecasts
According to 5 analysts, the average rating for BLI stock is "Buy." The 12-month stock price forecast is 95.50, which is an increase of 104.23% from the latest price.